97 related articles for article (PubMed ID: 2479848)
1. [Pharmacokinetics of neocarzinostatin in patients with malignant glioma. Quantitative analysis of tissue concentration].
Otsuka T; Matsukado Y; Uemura S; Kuratsu J; Sonoda H; Mihara Y; Goto S
Neurol Med Chir (Tokyo); 1989 Jun; 29(6):471-5. PubMed ID: 2479848
[TBL] [Abstract][Full Text] [Related]
2. [Uptake and localization of neocarzinostatin in malignant glioma. Experimental study by immunofluorescent staining method].
Otsuka T; Matsukado Y; Uemura S; Kuratsu J; Mihara Y; Yoshioka S; Goto S
Neurol Med Chir (Tokyo); 1989 Aug; 29(8):689-95. PubMed ID: 2479861
[TBL] [Abstract][Full Text] [Related]
3. Synergistic Anti-glioma Effects in Vitro and in Vivo of Enediyne Antibiotic Neocarzinostatin and Paclitaxel via Enhanced Growth Delay and Apoptosis-Induction.
Tianqin G; Chunlei C; Jingjing W
Biol Pharm Bull; 2016 Oct; 39(10):1623-1630. PubMed ID: 27431785
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of a rat meningeal gliomatosis model with neocarzinostatin].
Yoshida T; Shimizu K; Ushio Y; Mogami H; Sakamoto Y; Egawa T
No To Shinkei; 1987 Jul; 39(7):615-9. PubMed ID: 2960332
[TBL] [Abstract][Full Text] [Related]
5. Increased serum stability and prolonged biological half-life of neocarzinostatin covalently bound to monoclonal antibodies.
Gottschalk U; Garnett MC; Ward RK; Maibücher A; Köhnlein W
J Antibiot (Tokyo); 1991 Oct; 44(10):1148-54. PubMed ID: 1835456
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacokinetics and antitumor activity of MX2, a new morpholino anthracycline in brain tumor intracerebral transplanted in rats].
Kiya K; Ogasawara H; Fujita H; Sugiyama K; Kurisu K; Kawamoto K; Uozumi T; Shinkai H
Gan To Kagaku Ryoho; 1993 Apr; 20(5):631-5. PubMed ID: 8470921
[TBL] [Abstract][Full Text] [Related]
7. Effect of blood, ascites, and tumor cell density on cytocidal action of neocarzinostatin.
Shimoyama M; Kimura K
Gan; 1979 Apr; 70(2):165-71. PubMed ID: 157307
[TBL] [Abstract][Full Text] [Related]
8. Decreased production of anti-mouse antibody after administration of human/mouse chimeric monoclonal antibody-neocarzinostatin conjugate to human.
Yata Y; Otsuji E; Okamoto K; Tsuruta H; Kobayashi S; Toma A; Yamagishi H
Hepatogastroenterology; 2003; 50(49):80-4. PubMed ID: 12629996
[TBL] [Abstract][Full Text] [Related]
9. Specific cytotoxic effect of neocarzinostatin conjugated to monoclonal antibody A7 on human pancreatic carcinoma.
Otsuji E; Takahashi T; Yamaguchi T; Yamaguchi N; Imanishi J
Gastroenterol Jpn; 1990 Apr; 25(2):244-8. PubMed ID: 2140808
[TBL] [Abstract][Full Text] [Related]
10. Potentiation of cytotoxicity of zinostatin under acidic conditions in vitro and in vivo.
Kuroiwa T; Taniguchi S; Aoki K; Hasuda K; Baba T
Cancer Treat Rep; 1987 Mar; 71(3):247-51. PubMed ID: 2949830
[TBL] [Abstract][Full Text] [Related]
11. Enzyme immunoassay with high sensitivity and accuracy for specific antibody to neocarzinostatin.
Kitagawa T; Tanimori H; Yoshida K
J Immunol Methods; 1984 Aug; 72(1):297-303. PubMed ID: 6235292
[TBL] [Abstract][Full Text] [Related]
12. [Tumor growth inhibitory effects of SMANCS, a poly (styrene-maleic acid) conjugated derivative of neocarzinostatin, on various tissue culture cells].
Suzuki F; Okuno Y; Maeda Y; Maeda H
Gan To Kagaku Ryoho; 1987 Dec; 14(12):3305-12. PubMed ID: 2961306
[TBL] [Abstract][Full Text] [Related]
13. A pharmacokinetic simulation model for chemotherapy of brain tumor with an antitumor protein antibiotic, neocarzinostatin. Theoretical considerations behind a two-compartment model for continuous infusion via an internal carotid artery.
Maeda H; Sano Y; Takeshita J; Iwai Z; Kosaka H; Marubayashi T; Matsukado Y
Cancer Chemother Pharmacol; 1981; 5(4):243-9. PubMed ID: 6455212
[TBL] [Abstract][Full Text] [Related]
14. Enzyme-linked immunosorbent assay of neocarzinostatin chromophore (NCS-chr) by use of a monoclonal antibody against NCS-chr analog.
Mizugaki M; Itoh K; Nakamura H; Ishida N
J Immunoassay; 1996 May; 17(2):133-44. PubMed ID: 8744283
[TBL] [Abstract][Full Text] [Related]
15. Antitumour activity of an immunoconjugate composed of anti-human astrocytoma monoclonal antibody and neocarzinostatin.
Kondo S; Nakatsu S; Sakahara H; Kobayashi H; Konishi J; Namba Y
Eur J Cancer; 1993; 29A(3):420-3. PubMed ID: 8398344
[TBL] [Abstract][Full Text] [Related]
16. The antitumor effect of MX2, a new morpholino anthracycline, against malignant glioma cell lines and its subcellular distribution.
Kabuto M; Kubota T; Kobayashi H; Nakagawa T; Kitai R
Neurosurgery; 1995 Sep; 37(3):471-6; discussion 476-7. PubMed ID: 7501112
[TBL] [Abstract][Full Text] [Related]
17. Gene transcription analysis of Saccharomyces cerevisiae exposed to neocarzinostatin protein-chromophore complex reveals evidence of DNA damage, a potential mechanism of resistance, and consequences of prolonged exposure.
Schaus SE; Cavalieri D; Myers AG
Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11075-80. PubMed ID: 11562456
[TBL] [Abstract][Full Text] [Related]
18. [Intra-operative administration of neocarzinostatin into the duodenal subserosa and levels found in the regional lymph nodes in pancreato-duodenal cancer].
Hase Y; Kondo T; Nakagawa H; Matsumoto T; Maekawa T; Sakakibara N
Gan To Kagaku Ryoho; 1987 Nov; 14(11):3119-24. PubMed ID: 2960268
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and specificity of a monoclonal antibody-drug conjugate in chemotherapy by intratumoral injection.
Kitamura K; Takahashi T; Miyagaki T; Yamaoka N; Tsurumi H; Ohtsuji E; Kamiguchi M; Noguchi A; Yamaguchi T
Jpn J Cancer Res; 1992 Jul; 83(7):769-74. PubMed ID: 1387634
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic effect of neocarzinostatin on human lymphoid cells.
Maeda H; Matsumoto M
Tohoku J Exp Med; 1979 Aug; 128(4):313-23. PubMed ID: 225845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
